Public preview. Funding rounds, founders, and growth signals require a free account.

Eleven Biotherapeutics, Inc. (CARM)

Based on SEC filing data. A Cambridge-based biotech corporation raised $996,016 in Series B equity funding. The company operates in the biotechnology sector.

Series BBiotechCambridge, MA

Total raised

$47.8M

Last round

Equity

$996K · Mar 2018

Stage

Series B

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Sign up to see founders

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Create free account

Growth signals

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Sign up to see signals

Free account unlocks 5 full profiles per day. Pro removes the limit.

Create free account

Track Eleven Biotherapeutics, Inc. (CARM) on FlareSight

Get notified the moment Eleven Biotherapeutics, Inc. (CARM) files a new round, hires execs, or shows traction signals.

Create free account

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.